查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1387357

抗高血壓藥物市場報告：2030 年趨勢、預測與競爭分析

Antihypertensive Drug Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

抗高血壓藥物趨勢與預測

預計2024年至2030年全球抗高血壓藥物市場將以4.7%的複合年成長率成長。這個市場的主要促進因素是高血壓盛行率的增加、私人和政府機構的配合措施和計劃的增加以及人們對高血壓的認知不斷提高。全球降血壓藥市場前景廣闊，零售藥局、醫院藥局、電商市場都有商機。

抗高血壓藥物市場洞察

Lucintel 預測，與其他療法相比，鈣通道拮抗由於其價格實惠、療效更高且副作用更少，預計在預測期內仍將是最大的區隔市場。

由於全球醫院數量不斷增加，醫院仍然是該市場中最大的部分。

由於高血壓盛行率迅速上升和老年人口不斷增加，北美在預測期內可能仍然是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3. 哪個地區的成長速度會更快？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5.市場上的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球抗高血壓藥物市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球抗高血壓藥物市場趨勢（2018-2023）與預測（2024-2030）
  • 依治療藥物類別分類的全球抗高血壓藥物市場
    • 利尿劑
    • ACE抑制劑
    • 鈣拮抗
    • 血管擴張劑
    • BETA-腎上腺素阻斷劑
    • 其他
  • 依配銷通路的全球抗高血壓藥物市場
    • 零售藥房
    • 醫院藥房
    • 電子商務
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球抗高血壓藥物市場區域分佈
  • 北美降血壓藥市場
  • 歐洲抗高血壓藥物市場
  • 亞太地區抗高血壓藥物市場
  • 其他地區降血壓藥市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依治療藥物類別分類的全球抗高血壓藥物市場成長機會
    • 全球抗高血壓藥物市場成長機會（依配銷通路）
    • 全球抗高血壓藥物市場依地區成長機會
  • 全球抗高血壓藥物市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球抗高血壓藥物市場的產能擴張
    • 全球抗高血壓藥物市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Lupin
  • Boehringer Ingelheim International
  • Sun PharmACEutical Industries
  • AstraZeneca
  • Novartis
  • SANOFI
  • Merck
簡介目錄

Antihypertensive Drug Trends and Forecast

The future of the global antihypertensive drug market looks promising with opportunities in the retail pharmacy, hospital pharmacy, and e-commerce markets. The global antihypertensive drug market is expected to grow with a CAGR of 4.7% from 2024 to 2030. The major drivers for this market are growing incidence of hypertension, rising efforts and initiatives by both private and government organizations, and increasing awareness of hypertension.

A more than 150-page report is developed to help in your business decisions.

Antihypertensive Drug by Segment

The study includes a forecast for the global antihypertensive drug by therapeutic class, distribution channel, and region.

Antihypertensive Drug Market by Therapeutic Class [Shipment Analysis by Value from 2018 to 2030]:

  • Diuretics
  • ACE Inhibitors
  • Calcium Channel Blockers
  • Vasodilators
  • Beta-Adrenergic Blockers
  • Others

Antihypertensive Drug Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Retail Pharmacy
  • Hospital Pharmacy
  • E-Commerce
  • Others

Antihypertensive Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Antihypertensive Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies antihypertensive drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the antihypertensive drug companies profiled in this report include-

  • Lupin
  • Boehringer Ingelheim International
  • Sun PharmACEutical Industries
  • Astrazeneca
  • Novartis
  • SANOFI
  • Merck

Antihypertensive Drug Market Insights

Lucintel forecasts that calcium channel blocker will remain the largest segment over the forecast period due to its affordability, high efficacy, and lesser side effects as compare to other therapeutic classes.

Within this market, hospital will remain the largest segment due to increase in number of hospitals worldwide.

North America will remain the largest region over the forecast period due to surge in incidence of hypertension and rise in geriatric population.

Features of the Global Antihypertensive Drug Market

Market Size Estimates: Antihypertensive drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Antihypertensive drug market size by therapeutic class, distribution channel, and region in terms of value ($B).

Regional Analysis: Antihypertensive drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapeutic classes, distribution channels, and regions for the antihypertensive drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the antihypertensive drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for antihypertensive drug market?

Answer: The global antihypertensive drug market is expected to grow with a CAGR of 4.7% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the antihypertensive drug market?

Answer: The major drivers for this market are growing incidence of hypertension, rising efforts and initiatives by both private and government organizations, and increasing awareness of hypertension.

Q3. What are the major segments for antihypertensive drug market?

Answer: The future of the antihypertensive drug market looks promising with opportunities in the retail pharmacy, hospital pharmacy, and e-commerce markets.

Q4. Who are the key antihypertensive drug market companies?

Answer: Some of the key antihypertensive drug companies are as follows:

  • Lupin
  • Boehringer Ingelheim International
  • Sun PharmACEutical Industries
  • Astrazeneca
  • Novartis
  • SANOFI
  • Merck

Q5. Which antihypertensive drug market segment will be the largest in future?

Answer: Lucintel forecasts that calcium channel blocker will remain the largest segment over the forecast period due to its affordability, high efficacy, and lesser side effects as compare to other therapeutic classes.

Q6. In antihypertensive drug market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to surge in incidence of hypertension and rise in geriatric population.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the antihypertensive drug market by therapeutic class (diuretics, ACE inhibitors, calcium channel blockers, vasodilators, beta-adrenergic blockers, and others), distribution channel (retail pharmacy, hospital pharmacy, e-commerce, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pACE and why?
  • Q.3. Which region will grow at a faster pACE and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Antihypertensive Drug Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Antihypertensive Drug Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Antihypertensive Drug Market by Therapeutic Class
    • 3.3.1: Diuretics
    • 3.3.2: ACE Inhibitors
    • 3.3.3: Calcium Channel Blockers
    • 3.3.4: Vasodilators
    • 3.3.5: Beta-adrenergic Blockers
    • 3.3.6: Others
  • 3.4: Global Antihypertensive Drug Market by Distribution Channel
    • 3.4.1: Retail Pharmacy
    • 3.4.2: Hospital Pharmacy
    • 3.4.3: E-commerce
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Antihypertensive Drug Market by Region
  • 4.2: North American Antihypertensive Drug Market
    • 4.2.2: North American Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others
  • 4.3: European Antihypertensive Drug Market
    • 4.3.1: European Antihypertensive Drug Market by Therapeutic Class: Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others
    • 4.3.2: European Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others
  • 4.4: APAC Antihypertensive Drug Market
    • 4.4.1: APAC Antihypertensive Drug Market by Therapeutic Class: Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others
    • 4.4.2: APAC Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others
  • 4.5: ROW Antihypertensive Drug Market
    • 4.5.1: ROW Antihypertensive Drug Market by Therapeutic Class: Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others
    • 4.5.2: ROW Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Antihypertensive Drug Market by Therapeutic Class
    • 6.1.2: Growth Opportunities for the Global Antihypertensive Drug Market by Distribution Channel
    • 6.1.3: Growth Opportunities for the Global Antihypertensive Drug Market by Region
  • 6.2: Emerging Trends in the Global Antihypertensive Drug Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Antihypertensive Drug Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Antihypertensive Drug Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Lupin
  • 7.2: Boehringer Ingelheim International
  • 7.3: Sun PharmACEutical Industries
  • 7.4: AstraZeneca
  • 7.5: Novartis
  • 7.6: SANOFI
  • 7.7: Merck